---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-134184"
form_type: "8-K"
ticker: null
cik: "0001577916"
company_name: "Premier, Inc."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T09:59:55.887866+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Premier Q3 FY2024: Revenue $342.6M (+6% YoY), GAAP loss $(0.36)/share due to $140.1M impairment, reaffirms FY outlook

## Summary
- Total net revenue $342.6M (+6% YoY); Supply Chain Services $227.7M (+5%), Performance Services $115.0M (+9%).
- GAAP net loss $49.2M ($(0.36) diluted EPS) due to $140.1M impairment on Contigo Health business.
- Adjusted EPS $0.55, flat YoY; fiscal 2024 guidance reaffirmed.
- Executed $400M accelerated share repurchase, expected to fully settle by Q1 fiscal 2025.

## SEC filing metadata
- accession: 0001193125-24-134184
- form_type: 8-K
- cik: 0001577916
- company_name: Premier, Inc.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1577916/000119312524134184/0001193125-24-134184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1577916/000119312524134184/d827328d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-134184
- JSON: https://secwatch.observer/filing/0001193125-24-134184.json
- Plain text: https://secwatch.observer/filing/0001193125-24-134184.txt

## Key facts
- Earnings Releases
  Premier, Inc. reported the fiscal-year 2024 third quarter ended March 31, 2024 results: revenue Total net revenue of $342.6 million, net income GAAP net loss of $49.2 million, or $(0.36) per fully diluted share. Guidance reaffirmed.
  - Period: the fiscal-year 2024 third quarter ended March 31, 2024
  - Revenue: Total net revenue of $342.6 million
  - Net income: GAAP net loss of $49.2 million, or $(0.36) per fully diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: healthcare improvement company, today reported financial results for the fiscal-year 2024 third quarter ended March 31, 2024. Third-quarter results: • Total net revenue of $342.6 million; growth of 6% over the prior-year period • GAAP net loss of $49.2 million, or $(0.36) per fully diluted share, which includes a $140.1 million goodwill, intangible and other
  evidence_url: https://www.sec.gov/Archives/edgar/data/1577916/000119312524134184/0001193125-24-134184-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.